These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

533 related items for PubMed ID: 18082874

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents.
    Kalsekar ID, Madhavan SS, Amonkar MM, Makela EH, Scott VG, Douglas SM, Elswick BL.
    Ann Pharmacother; 2006 Apr; 40(4):605-11. PubMed ID: 16551768
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy.
    Segal JB, Dy SM, Millman EA, Herbert R, Bass EB, Wu A.
    Clin Ther; 2007 Aug; 29(8):1784-94. PubMed ID: 17919559
    [Abstract] [Full Text] [Related]

  • 7. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis.
    Vanderpoel DR, Hussein MA, Watson-Heidari T, Perry A.
    Clin Ther; 2004 Dec; 26(12):2066-75. PubMed ID: 15823770
    [Abstract] [Full Text] [Related]

  • 8. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients.
    Cheong C, Barner JC, Lawson KA, Johnsrud MT.
    Clin Ther; 2008 Oct; 30(10):1893-907. PubMed ID: 19014846
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
    Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL.
    Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data.
    Grant RW, Singer DE, Meigs JB.
    Clin Ther; 2005 Jun; 27(6):773-81. PubMed ID: 16117984
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prescriptions for vitamin D among patients taking antiresorptive agents in Canada.
    Hanley DA, Zhang Q, Meilleur MC, Mavros P, Sen SS.
    Curr Med Res Opin; 2007 Jun; 23(6):1473-80. PubMed ID: 17559742
    [Abstract] [Full Text] [Related]

  • 15. Using a pharmaco-epidemiological approach to estimate diabetes type 2 prevalence in Portugal.
    Duarte-Ramos F, Cabrita J.
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):269-74. PubMed ID: 16294365
    [Abstract] [Full Text] [Related]

  • 16. The association between pharmacy closures and prescription drug use: a retrospective analysis of Medicaid prescription claims in Iowa.
    Xiao H, Sorofman B, Manasse HR.
    Am J Manag Care; 2000 Mar; 6(3):366-72. PubMed ID: 10977436
    [Abstract] [Full Text] [Related]

  • 17. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis.
    Adeyemi AO, Rascati KL, Lawson KA, Strassels SA.
    Clin Ther; 2012 Mar; 34(3):712-9. PubMed ID: 22381712
    [Abstract] [Full Text] [Related]

  • 18. Using propensity scores subclassification to estimate effects of longitudinal treatments: an example using a new diabetes medication.
    Segal JB, Griswold M, Achy-Brou A, Herbert R, Bass EB, Dy SM, Millman AE, Wu AW, Frangakis CE.
    Med Care; 2007 Oct; 45(10 Supl 2):S149-57. PubMed ID: 17909374
    [Abstract] [Full Text] [Related]

  • 19. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
    Spoelstra JA, Stolk RP, Heerdink ER, Klungel OH, Erkens JA, Leufkens HG, Grobbee DE.
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
    [Abstract] [Full Text] [Related]

  • 20. Factors related to antipsychotic oversupply among Central Texas Veterans.
    Yang M, Barner JC, Worchel J.
    Clin Ther; 2007 Jun; 29(6):1214-25. PubMed ID: 17692735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.